Alnylam Pharmaceuticals
Alnylam issued U.S. patent broadly covering RNAi therapeutics
Published in Medicine and Law Weekly, July 7th, 2006
The U.S. patent (U.S. Patent No. 7,056,704) broadly covers methods of making small interfering RNAs (siRNAs), the molecules that mediate RNAi. The issued patent is exclusively licensed to Alnylam for RNAi therapeutics on a worldwide basis through an agreement with Garching Innovation GmbH, the licensing agent for the Max Planck Society.
The new patent stems from groundbreaking research published in 2001 in the journal Nature by Thomas Tuschl, PhD, a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Accu-Break Pharmaceuticals
Accu-Break, Strides Arcolab enter joint venture to develop generic pharmaceuticals - Awards
Humana wins Stevie Award for best new product - Baylor College of Medicine, U.S.
Ethics for clinical trials enrollment for women of childbearing potential emphasized - Biophan Technologies
Biophan is issued U.S. patents related to cardiac pacing - Bradmer Pharmaceuticals
Bradmer extends patent portfolio with allowance letter from European Patent Office - Business Update
Children's Hospital of Orange County implements High Tower SEM 3210, addressing security, HIPAA - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
